Humana Inc. reaffirmed its full-year 2026 guidance of at least $8.89 in diluted earnings per share and at least $9.00 in adjusted earnings per share during upcoming investor meetings in March. While the company does not expect changes to its adjusted EPS guidance, it noted that GAAP EPS guidance may be subject to change due to ongoing strategic initiatives.
